4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NovoCure Limited (NVCR) operates in the Medical Devices industry and is headquartered in Baar, Switzerland with about 1,605 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, NVCR reported $655M in revenue and ($136M) in net income.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.
Interactive charts & full statements → Open the NVCR valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $655M | $605M | $509M | $538M |
| Gross Profit | $488M | $468M | $381M | $423M |
| Operating Income (EBIT) | ($154M) | ($170M) | ($233M) | ($90M) |
| Net Income | ($136M) | ($169M) | ($207M) | ($92M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $174M | $174M | $167M | $159M | $155M |
| Gross Profit | $135M | $132M | $122M | $117M | $116M |
| Operating Income (EBIT) | ($67M) | ($40M) | ($36M) | ($40M) | ($38M) |
| Net Income | ($71M) | ($24M) | ($37M) | ($40M) | ($34M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $804M | $1.2B | $1.1B | $1.2B | — |
| Total Liabilities | $464M | $881M | $784M | $750M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NVCR viewer.
About TickerBase · Data methodology & sources